Seiichi Kiso
Amministratore Delegato presso Life Science Institute, Inc.
Profilo
Dr. Seiichi Kiso is a President, Chief Executive Officer & Director at Life Science Institute, Inc. He is on the Board of Directors at LSI Medience Corp., The Kaiteki Institute, Inc. and Life Science Institute, Inc. Dr. Kiso was previously employed as an Executive Officer by Mitsubishi Tanabe Pharma Corp., a Non-Executive Director by API Corp., and an Executive Officer & Manager-Healthcare Solutions by Mitsubishi Chemical Group Corp.
He also served on the board at Cytochroma, Inc. and Qualicaps Co., Ltd.
He received his graduate degree from Kyoto Pharmaceutical University, an MBA from Kobe University and a doctorate degree from Nagoya University.
Posizioni attive di Seiichi Kiso
| Società | Posizione | Inizio |
|---|---|---|
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - |
Life Science Institute, Inc.
 Life Science Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Institute, Inc. provides clinical testing and pharmaceutical development support activities. The company is headquartered in Tokyo, Japan. | Amministratore Delegato | - |
LSI Medience Corp.
 LSI Medience Corp. Medical SpecialtiesHealth Technology LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Seiichi Kiso
| Società | Posizione | Fine |
|---|---|---|
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Direttore/Membro del Consiglio | 16/06/2011 |
API Corp.
 API Corp. Pharmaceuticals: MajorHealth Technology API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - |
Qualicaps Co., Ltd.
 Qualicaps Co., Ltd. Pharmaceuticals: MajorHealth Technology Qualicaps Co., Ltd. manufactures and markets hard gelatin and HPMC capsules, capsule filling equipment, and sealing machinery. Its products include pharmaceutical and health food capsules, capsule filling machines, capsule filling machine auger type, capsule weight inspection machine, laser imprinting system, and tablet imprinting machine. The company was founded on April 26, 1965 and is headquartered in Yamatokoriyama, Japan. | Direttore/Membro del Consiglio | - |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Formazione di Seiichi Kiso
| Kobe University | Masters Business Admin |
| Nagoya University | Doctorate Degree |
| Kyoto Pharmaceutical University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| Aziende private | 7 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Cytochroma, Inc.
Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Qualicaps Co., Ltd.
Qualicaps Co., Ltd. Pharmaceuticals: MajorHealth Technology Qualicaps Co., Ltd. manufactures and markets hard gelatin and HPMC capsules, capsule filling equipment, and sealing machinery. Its products include pharmaceutical and health food capsules, capsule filling machines, capsule filling machine auger type, capsule weight inspection machine, laser imprinting system, and tablet imprinting machine. The company was founded on April 26, 1965 and is headquartered in Yamatokoriyama, Japan. | Health Technology |
API Corp.
API Corp. Pharmaceuticals: MajorHealth Technology API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Health Technology |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
Life Science Institute, Inc.
Life Science Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Institute, Inc. provides clinical testing and pharmaceutical development support activities. The company is headquartered in Tokyo, Japan. | Commercial Services |
LSI Medience Corp.
LSI Medience Corp. Medical SpecialtiesHealth Technology LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Seiichi Kiso